rs1554708795
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PP3PP5_Moderate
The ENST00000429896.6(PTCH1):c.-252-16_-227delTCTGCTTCGTCCCCAGGGGAAGGCTACTGGCCGGAAAGCGCC variant causes a splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
ENST00000429896.6 splice_region
Scores
Clinical Significance
Conservation
Publications
- basal cell nevus syndrome 1Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- holoprosencephaly 7Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- nevoid basal cell carcinoma syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- holoprosencephalyInheritance: AD Classification: LIMITED Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PTCH1 | NM_000264.5 | c.202-16_227delTCTGCTTCGTCCCCAGGGGAAGGCTACTGGCCGGAAAGCGCC | p.Gly68fs | frameshift_variant, splice_acceptor_variant, splice_region_variant, intron_variant | Exon 2 of 24 | ENST00000331920.11 | NP_000255.2 | |
| PTCH1 | NM_001083603.3 | c.199-16_224delTCTGCTTCGTCCCCAGGGGAAGGCTACTGGCCGGAAAGCGCC | p.Gly67fs | frameshift_variant, splice_acceptor_variant, splice_region_variant, intron_variant | Exon 2 of 24 | ENST00000437951.6 | NP_001077072.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PTCH1 | ENST00000331920.11 | c.202-16_227delTCTGCTTCGTCCCCAGGGGAAGGCTACTGGCCGGAAAGCGCC | p.Gly68fs | frameshift_variant, splice_acceptor_variant, splice_region_variant, intron_variant | Exon 2 of 24 | 5 | NM_000264.5 | ENSP00000332353.6 | ||
| PTCH1 | ENST00000437951.6 | c.199-16_224delTCTGCTTCGTCCCCAGGGGAAGGCTACTGGCCGGAAAGCGCC | p.Gly67fs | frameshift_variant, splice_acceptor_variant, splice_region_variant, intron_variant | Exon 2 of 24 | 5 | NM_001083603.3 | ENSP00000389744.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Gorlin syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant is an out-of-frame deletion of the genomic region encompassing part of exon 2 of the PTCH1 gene including the exon 2-intron 2 boundary (c.202-16_227del). This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with PTCH1-related disease. Loss-of-function variants in PTCH1 are known to be pathogenic (PMID: 16301862, 16419085). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at